Caregen Co., Ltd. (KOSDAQ:214370)
South Korea · Delayed Price · Currency is KRW 72,600
-1,900 (-2.55%)
Jun 10, 2026, 3:30 PM KST
Caregen Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 74,220 | 72,808 | 82,586 | 79,210 | 69,098 | 59,088 |
Other Revenue | -0 | -0 | - | - | -0 | - |
| 74,220 | 72,808 | 82,586 | 79,210 | 69,098 | 59,088 | |
Revenue Growth (YoY) | -11.04% | -11.84% | 4.26% | 14.63% | 16.94% | -2.00% |
Cost of Revenue | 21,281 | 20,611 | 27,314 | 20,914 | 16,795 | 13,644 |
Gross Profit | 52,939 | 52,197 | 55,272 | 58,296 | 52,302 | 45,444 |
Selling, General & Admin | 12,200 | 11,335 | 11,227 | 10,257 | 10,776 | 10,712 |
Research & Development | 5,574 | 5,756 | 7,011 | 5,824 | 6,285 | 5,026 |
Amortization of Goodwill & Intangibles | 975.38 | 945.1 | 842.66 | 692.76 | 524.71 | 346.82 |
Other Operating Expenses | 470.38 | 457.61 | 375.15 | 267.8 | 269.65 | 264.48 |
Operating Expenses | 32,494 | 31,798 | 21,022 | 17,935 | 18,700 | 17,335 |
Operating Income | 20,445 | 20,400 | 34,250 | 40,360 | 33,603 | 28,109 |
Interest & Investment Income | 315.11 | 330.88 | 999.04 | 3,669 | 596.42 | 358.28 |
Currency Exchange Gain (Loss) | 1,894 | -655.11 | 3,674 | 2,313 | -168.55 | 3,022 |
Other Non Operating Income (Expenses) | 311.54 | 335.33 | -186.88 | 677.94 | 59.79 | 1,203 |
EBT Excluding Unusual Items | 22,966 | 20,411 | 38,736 | 47,021 | 34,090 | 32,692 |
Gain (Loss) on Sale of Investments | 1,846 | 1,929 | 1,437 | 2,552 | 368.74 | 805.62 |
Gain (Loss) on Sale of Assets | -0.67 | 10.2 | -6.36 | - | -2.01 | 15.33 |
Asset Writedown | - | - | - | - | - | 68.09 |
Pretax Income | 24,811 | 22,350 | 40,167 | 49,572 | 34,457 | 33,581 |
Income Tax Expense | 1,448 | 2,252 | 7,853 | 9,642 | 7,240 | 8,397 |
Earnings From Continuing Operations | 23,363 | 20,099 | 32,314 | 39,930 | 27,217 | 25,184 |
Minority Interest in Earnings | - | - | - | - | 50.01 | 134.14 |
Net Income | 23,363 | 20,099 | 32,314 | 39,930 | 27,267 | 25,318 |
Net Income to Common | 23,363 | 20,099 | 32,314 | 39,930 | 27,267 | 25,318 |
Net Income Growth | -25.17% | -37.80% | -19.07% | 46.44% | 7.70% | -19.57% |
Shares Outstanding (Basic) | 49 | 49 | 49 | 49 | 49 | 49 |
Shares Outstanding (Diluted) | 49 | 49 | 49 | 49 | 49 | 49 |
Shares Change (YoY) | -0.46% | -0.48% | -0.05% | 0.13% | 0.08% | -0.52% |
EPS (Basic) | 478.26 | 411.26 | 658.00 | 812.68 | 555.68 | 516.39 |
EPS (Diluted) | 478.26 | 411.26 | 658.00 | 812.68 | 555.68 | 516.39 |
EPS Growth | -24.80% | -37.50% | -19.03% | 46.25% | 7.61% | -19.14% |
Free Cash Flow | 18,780 | 14,729 | -52,380 | 20,447 | -29,225 | 47,970 |
Free Cash Flow Per Share | 384.44 | 301.39 | -1066.62 | 416.15 | -595.58 | 978.39 |
Gross Margin | 71.33% | 71.69% | 66.93% | 73.60% | 75.69% | 76.91% |
Operating Margin | 27.55% | 28.02% | 41.47% | 50.95% | 48.63% | 47.57% |
Profit Margin | 31.48% | 27.61% | 39.13% | 50.41% | 39.46% | 42.85% |
Free Cash Flow Margin | 25.30% | 20.23% | -63.42% | 25.81% | -42.30% | 81.18% |
EBITDA | 25,480 | 25,418 | 39,406 | 45,342 | 37,053 | 30,145 |
EBITDA Margin | 34.33% | 34.91% | 47.72% | 57.24% | 53.62% | 51.02% |
D&A For EBITDA | 5,035 | 5,018 | 5,156 | 4,982 | 3,450 | 2,036 |
EBIT | 20,445 | 20,400 | 34,250 | 40,360 | 33,603 | 28,109 |
EBIT Margin | 27.55% | 28.02% | 41.47% | 50.95% | 48.63% | 47.57% |
Effective Tax Rate | 5.84% | 10.07% | 19.55% | 19.45% | 21.01% | 25.00% |
Advertising Expenses | - | 2,397 | 2,927 | 1,904 | 1,807 | 355.34 |